Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina

Circulation

Volumn 104, Issue 7, 2001, Pages 746-749

  Smith, David A ^a   Irving, Sandra D ^a   Sheldon, Joanna ^a   Cole, Della ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angina; Coronary disease; Interleukins

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; HEART PROTECTION; HUMAN; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

EID: 0035859839     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3201.094973     Document Type: Article

References (35)

1. Atherosclerosis: An inflammatory disease
2. Stability and instability: The two faces of coronary atherosclerosis
3. Molecular basis of the acute coronary syndromes
4. Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture
5. Matrix metalloproteinases and cardiovascular disease
6. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization
7. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
8. Transient intermittent lymphocyte activation is responsible for the instability of angina
9. Interleukin-8 as a sensitive marker of unstable coronary artery disease
10. Serum interleukin-6 in suspected myocardial infarction
11. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
12. Elevated levels of pro-inflammatory cytokines in coronary artery thrombi
13. Immunosuppressive and anti-inflammatory properties of interleukin 10
14. Interleukin (IL)-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
15. Cross regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis
16. Expression of interleukin-10 in advanced human atherosclerotic plaques
17. Protective role of interleukin-10 in atherosclerosis
18. Interleukin-10 blocks atherosclerotic events in vitro and in vivo
19. Unstable angina: A classification
20. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors
21. Serum neopterin and complex stenosis morphology in patients with unstable angina
22. Elevated levels of interleukin-6 in unstable angina
23. Interleukin (IL)-10 inhibits nuclear factor κB (NF-κB) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
24. In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13
25. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes
26. IL-10 inhibits LPS-induced human monocyte tissue factor expression in whole blood
27. Interleukin 10 suppression of monocyte prostaglandin H synthase-2: Mechanism of prostaglandin-dependent matrix metalloproteinase production
28. Endogenous interleukin 10 prevents apoptosis in macrophages during salmonella infection
29. Interleukin-10 rescues T cells from apoptotic cell death: Association with an upregulation of Bcl-2
30. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction
31. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations
32. Interleukin-10 concentration in children undergoing cardiopulmonary bypass
33. Human cytokine responses to cardiac transplantation and coronary artery bypass graft surgery
34. Crucial role of endogenous interleukin-10 production in myocardial ischaemia/reperfusion injury
35. IL-10: An "immunologic scalpel" for atherosclerosis?